rilpivirine hydrochloride structure
|
Common Name | rilpivirine hydrochloride | ||
---|---|---|---|---|
CAS Number | 700361-47-3 | Molecular Weight | 402.88 | |
Density | N/A | Boiling Point | N/A | |
Molecular Formula | C22H19ClN6 | Melting Point | N/A | |
MSDS | N/A | Flash Point | N/A |
Use of rilpivirine hydrochlorideRilpivirine (R278474) hydrochloride is a potent and specific diarylpyrimidine (DAPY) non-nucleoside reverse transcriptase inhibitor (NNRTI). Rilpivirine hydrochloride has high antiviral activity against wild-type HIV (EC50=0.4 nM) and mutant viruses (EC50=0.1-2.0 nM). Rilpivirine hydrochloride has a high genetic barrier to resistance development of HIV[1][2]. |
Name | rilpivirine hydrochloride |
---|---|
Synonym | More Synonyms |
Description | Rilpivirine (R278474) hydrochloride is a potent and specific diarylpyrimidine (DAPY) non-nucleoside reverse transcriptase inhibitor (NNRTI). Rilpivirine hydrochloride has high antiviral activity against wild-type HIV (EC50=0.4 nM) and mutant viruses (EC50=0.1-2.0 nM). Rilpivirine hydrochloride has a high genetic barrier to resistance development of HIV[1][2]. |
---|---|
Related Catalog | |
Target |
IC50: 20±10 μM (MMP)[1]Ki: 1.5±0.27 nM (MMPs)[1] |
In Vitro | R278474 对野生型 HIV-1 具有活性 (EC50=0.4 nM) 和所有测试的单突变体和双突变体 (EC50=0.1-2.0 nM)[1]。 R278474 (10-5000 nM; 30 d) 在 30 天内未观察到 1 μM 野生型 HIV-1 突破的迹象[1]。 R278474 在 50% 抑制浓度 (EC50) 小于 1 nM 时抑制 81% 的临床分离株(约 1200 种重组临床分离株),在 EC50 小于 10 nM 时则抑制 94%[1]。 TMC278 对野生型 HIV-1 M 组分离株 (0.07-1.01 nM) 显示亚纳摩尔的 EC50[2]。 |
In Vivo | R278474 (10-160 mg/kg; p.o. for 1 month) does not produce abnormal effects in rat, apart from liver weight increase and species-specific thyroid hypertrophy, both at the higher dose levels[1]. R278474 (i.v.) exhibits elimination half-life ranges from 4.4 h in rat to 31 h in dog, and exposure (AUCinf) amounts to 3.1 μg?h/mL (4 mg/kg) in rat, 8.7 μg?h/mL (1.25 mg/kg) in dog, 1.4 μg?h/mL (1.25 mg/ kg) in monkey, and 44?μg h/mL (1.25 mg/kg) in rabbit[1]. R278474 (p.o.) exhibits half-life ranges between 2.8 h in rat and 39 h in dog, and oral bioavailability of 32% and 31% in rat and dog[1]. |
References |
Molecular Formula | C22H19ClN6 |
---|---|
Molecular Weight | 402.88 |
Exact Mass | 402.13600 |
PSA | 100.65000 |
LogP | 5.28596 |
~% rilpivirine hyd... CAS#:700361-47-3 |
Literature: HETERO RESEARCH FOUNDATION; PARTHASARADHI REDDY, Bandi; RATHNAKAR REDDY, Kura; MURALIDHARA REDDY, Dasari; VENKAT NARSIMHA REDDY, Adulla; VAMSI KRISHNA, Bandi Patent: WO2013/38425 A1, 2013 ; Location in patent: Page/Page column 10; 11 ; |
Precursor 1 | |
---|---|
DownStream 0 |
Edurant |
4-[[4-[[4-(2-cyanoethenyl)-2,6-dimethylphenyl]amino]pyrimidin-2-yl]amino]benzonitrile hydrochloride |
TMC278 hydrochloride |
(E)-4-[[4-[[4-(2-cyanoethenyl)-2,6-dimethylphenyl]amino]-2-pyrimidinyl]amino]benzonitrile monohydrochloride |
Rilpivirine HCl |
Rilpivirine hydrochloride |
rilpivirine monohydrochloride |
4-[[4-[[4-(2-cyanoethenyl)-2,6-dimethylphenyl]amino]-2-pyrimidinyl]amino]benzonitrile monohydrochloride |
Edurant (TN) |
UNII-212WAX8KDD |
4-[[4-[4-[(E)-2-cyanoethenyl]-2,6-dimethylanilino]pyrimidin-2-yl]amino]benzonitrile,hydrochloride |